Montelukast Prescribing at ST PAULS PARTNERS
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
205
Total Quantity
6,790
NHS Cost
£286
vs National Avg
-70.1%
ST PAULS PARTNERS prescribed 205 items of Montelukast over the last 12 months at a cost of £286 to the NHS. This is 70.1% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
16
Jul 2026
18
Jul 2026
19
Jul 2026
14
Jul 2026
16
Jul 2026
19
Jul 2026
17
Jul 2026
20
Jul 2026
22
Jul 2026
11
Jul 2026
17
Jul 2026
16
Prescribing Details
| Total Items | 205 |
|---|---|
| Total Quantity | 6,790 |
| Total NHS Cost | £286 |
| Presentations | 3 different forms |
| vs National Average | -70.1% |
Montelukast Prescribing Comparison
| This practice | 205 items |
|---|---|
| National average per practice | 685 items |
| Difference | -70.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.